The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Open accessAbstract
The complex cross‐talk of intricate intercellular signaling networks between the tumor and stromal cells promotes cancer progression. Hypoxia is one of the most common conditions encountered within the tumor microenvironment that drives tumorigenesis. Most responses to hypoxia are elicited by a family of transcription factors called hypoxia‐inducible factors (HIFs), which induce expression of a diverse set of genes that assist cells to adapt to hypoxic environments. Among the three HIF protein family members, the role of HIF‐1 is well established in cancer progression. HIF‐1 functions as a signaling hub to coordinate the activities of many transcription factors and signaling molecules that impact tumorigenesis. This mini review discusses the complex role of HIF‐1 and its context‐dependent partners under various cancer‐promoting events including inflammation and generation of cancer stem cells, which are implicated in tumor metastasis and relapse. In addition, the review highlights the importance of therapeutic targeting of HIF‐1 for cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Gilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
RetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
RetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
RetractedGaredew, A., Henderson, S. O., & Moncada, S. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.27 · Cited by 127
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
(1999) · PubMed · Cited by 2,204
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity
Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040624 · Cited by 891
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., & Lendahl, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802047105 · Cited by 823
Lu, J., Tan, M., & Cai, Q. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 795
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Ikenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018866109 · Cited by 663
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
Medrek, C., Pontén, F., Jirström, K., & Leandersson, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-306 · Cited by 647
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 631
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
Disrupting proton dynamics and energy metabolism for cancer therapy
Parks, S. K., Chiche, J., & Pouysségur, J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3579 · Cited by 607
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Chronic Inflammation in Cancer Development
Multhoff, G., Molls, M., & Radons, J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00098 · Cited by 576
Innate Immune Recognition of Cancer
Woo, S.-R., Corrales, L., & Gajewski, T. F. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112043 · Cited by 571
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
Jiang, B., Agani, F. H., Passaniti, A., & Semenza, G. L. (1997) · PubMed · Cited by 532
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 501
Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., & Nizet, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7516 · Cited by 480
The Role of Hypoxia-Inducible Factor in Wound Healing
Hong, W. X., Hu, M. S., Esquivel, M., Liang, G. Y., Rennert, R. C., McArdle, A., Paik, K. J., Duscher, D., Gurtner, G. C., Lorenz, H. P., et al. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0520 · Cited by 448
Marin-Hernandez, A., Gallardo-Perez, J., Ralph, S., Rodriguez-Enriquez, S., & Moreno-Sanchez, R. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788922610 · Cited by 433
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., & Semenza, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3719 · Cited by 415
Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4697 · Cited by 414
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Wang, Y., Liu, Y., Malek, S. N., Zheng, P., & Liu, Y. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.02.006 · Cited by 410 · cited 1×
“The interplay between HIF-1 and Notch appears to be important for stem cell maintenance under hypoxia in a variety of cancer cell lines.(127,134,135) These studies highlight the important role of HIF-1 in CSC maintenance as one of the mechanisms by which HIF-1 promotes tumorigenesis and metastasis.”
BackgroundWhitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366
Cadherins and Epithelial-to-Mesenchymal Transition
Gheldof, A., & Berx, G. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394311-8.00014-5 · Cited by 361
Gordon, M. S. (2007) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70352-x · Cited by 346
Coffelt, S. B., Tal, A. O., Scholz, A., De Palma, M., Patel, S., Urbich, C., Biswas, S. K., Murdoch, C., Plate, K. H., Reiss, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0012 · Cited by 343
A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann, D. A., Seftor, E. A., Fong, S. F. T., Nieva, D. R. C., Sullivan, C. M., Edwards, E. M., Sommer, P., Csiszar, K., & Hendrix, M. J. C. (2002) · PubMed · Cited by 338
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 330
Mimeault, M., & Batra, S. K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12004 · Cited by 330
Qiang, L., Wu, T., Zhang, H.-W., Lu, N., Hu, R., Wang, Y.-J., Zhao, L., Chen, F.-H., Wang, X.-T., You, Q.-D., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.95 · Cited by 313
Tumor hypoxia and cancer progression
Zhou, J., Schmid, T., Schnitzer, S., & Brüne, B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.028 · Cited by 302
Hara, S., Hamada, J., Kobayashi, C., Kondo, Y., & Imura, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5659 · Cited by 282
Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt027 · Cited by 248
Zhang, P., Yao, Q., Lu, L., Li, Y., Chen, P.-J., & Duan, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.011 · Cited by 231
EMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Giannoni, E., Parri, M., & Chiarugi, P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4280 · Cited by 231
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
Pawlus, M. R., Wang, L., & Hu, C.-J. (2014) · Oncogene · doi:10.1038/onc.2013.115 · Cited by 226
Schito, L., Rey, S., Tafani, M., Zhang, H., Wong, C. C.-L., Russo, A., Russo, M. A., & Semenza, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214019109 · Cited by 224
Schwab, L. P., Peacock, D. L., Majumdar, D., Ingels, J. F., Jensen, L. C., Smith, K. D., Cushing, R. C., & Seagroves, T. N. (2012) · Breast Cancer Research · doi:10.1186/bcr3087 · Cited by 220
Simon, M., Tournaire, R., & Pouyssegur, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21558 · Cited by 219
Jiang, Y., Luo, Y., He, D., Li, X., Zhang, L., Peng, T., Li, M., & Lin, Y. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01866.x · Cited by 217
Yamagata, M., Hasuda, K., Stamato, T., & Tannock, I. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.289 · Cited by 212
Giannoni, E., Bianchini, F., Calorini, L., & Chiarugi, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3727 · Cited by 208
Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K., & Blagosklonny, M. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1734-1741.2002 · Cited by 207
Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer
Spivak-Kroizman, T. R., Hostetter, G., Posner, R., Aziz, M., Hu, C., Demeure, M. J., Von Hoff, D., Hingorani, S. R., Palculict, T. B., Izzo, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-11-1433 · Cited by 202
Shimoda, L. A., Fallon, M., Pisarcik, S., Wang, J., & Semenza, G. L. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00528.2005 · Cited by 202
Semenza, G. L. (2013) · Oncogene · doi:10.1038/onc.2012.578 · Cited by 201
Maxwell, P. J., Gallagher, R., Seaton, A., Wilson, C., Scullin, P., Pettigrew, J., Stratford, I. J., Williams, K. J., Johnston, P. G., & Waugh, D. J. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210536 · Cited by 199
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394307-1.00003-5 · Cited by 190
Yang, C., He, L., He, P., Liu, Y., Wang, W., He, Y., Du, Y., & Gao, F. (2015) · Medical Oncology · doi:10.1007/s12032-014-0352-6 · Cited by 189
Rapisarda, A., Zalek, J., Hollingshead, M., Braunschweig, T., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Hewitt, S. M., Shoemaker, R. H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2116 · Cited by 187
Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800854 · Cited by 183
Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y., & Lee, J. Y. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03203.x · Cited by 178
Shah, Y. M., Ito, S., Morimura, K., Chen, C., Yim, S., Haase, V. H., & Gonzalez, F. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.009 · Cited by 168
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
Oblak, A., & Jerala, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/609579 · Cited by 167
Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., & Brune, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq088 · Cited by 167
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
Nishi, K., Oda, T., Takabuchi, S., Oda, S., Fukuda, K., Adachi, T., Semenza, G. L., Shingu, K., & Hirota, K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1825 · Cited by 163
Targeting the HIF pathway in inflammation and immunity
Scholz, C. C., & Taylor, C. T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.009 · Cited by 161
Philip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
HIF-1α is upregulated in human mesenchymal stem cells
Palomäki, S., Pietilä, M., Laitinen, S., Pesälä, J., Sormunen, R. T., Lehenkari, P. P., & Koivunen, P. (2013) · Stem Cells · doi:10.1002/stem.1435 · Cited by 149
Singh, A. K., Arya, R. K., Maheshwari, S., Singh, A., Meena, S., Pandey, P., Dormond, O., & Datta, D. B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28804 · Cited by 147
Chuang, M., Sun, K., Tang, S., Deng, M., Wu, Y., Sung, J.-S., Cha, T., & Sun, G. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00756.x · Cited by 146
Vaupel, P. W., & Mayer, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0620-8_3 · Cited by 139
Fiaschi, T., Giannoni, E., Taddei, L., Cirri, P., Marini, A., Pintus, G., Nativi, C., Richichi, B., Scozzafava, A., Carta, F., et al. (2013) · Cell Cycle · doi:10.4161/cc.24902 · Cited by 139
Chafe, S. C., Lou, Y., Sceneay, J., Vallejo, M., Hamilton, M. J., McDonald, P. C., Bennewith, K. L., Möller, A., & Dedhar, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3000 · Cited by 138
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Poggi, A. D., Musso, A., Dapino, I., & Zocchi, M. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.03.001 · Cited by 130
The EGF/CSF-1 Paracrine Invasion Loop Can Be Triggered by Heregulin β1 and CXCL12
Hernández, L. B., Смирнова, Т. А., Kedrin, D., Wyckoff, J. B., Zhu, L., Stanley, E. R., Cox, D., Muller, W. J., Pollard, J. W., van Rooijen, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2871 · Cited by 128
ZHU, H., WANG, D., ZHANG, L., XIE, X., WU, Y., LIU, Y., SHAO, G., & SU, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3298 · Cited by 124
c-Jun and Hypoxia-Inducible Factor 1 Functionally Cooperate in Hypoxia-Induced Gene Transcription
Alfranca, A., Gutiérrez, M. D. C., Vara, A., Aragonés, J., Vidal, F., & Landázuri, M. O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.12-22.2002 · Cited by 123
Johnson, B. F., Clay, T. M., Hobeika, A. C., Lyerly, H. K., & Morse, M. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.4.449 · Cited by 121
Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells
Yeung, T. M., Gandhi, S. C., & Bodmer, W. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014519107 · Cited by 118
NO restores HIF-1α hydroxylation during hypoxia: Role of reactive oxygen species
Callapina, M., Zhou, J., Schmid, T., Köhl, R., & Brüne, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.009 · Cited by 118
In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics
Lao, B. B., Grishagin, I. V., Mesallati, H., Brewer, T. F., Olenyuk, B. Z., & Arora, P. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402393111 · Cited by 117
The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis
Balamurugan, K., Wang, J., Tsai, H.-H., Sharan, S., Anver, M. R., Leighty, R. M., & Sterneck, E. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.280 · Cited by 111
Self-citationChouaı̈b, S., Kiéda, C., Benlalam, H., Noman, M. Z., Mami‐Chouaib, F., & Rüegg, C. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i6.30 · Cited by 108
Noman, M. Z., Messai, Y., Carré, T., Akalay, I., Meron, M., Janji, B., Hasmim, M., & Chouaı̈b, S. (2011) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v31.i5.10 · Cited by 104
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression
Sanità, P., Capulli, M., Teti, A. M., Galatioto, G. P., Vicentini, C., Chiarugi, P., Bologna, M., & Angelucci, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-154 · Cited by 103
Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma
Zhang, J.-J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i23.2881 · Cited by 100
Cho, K. H., Choi, M., Jeong, K. J., Kim, J. J., Hwang, M. H., Shin, S. C., Park, C. G., & Lee, H. Y. (2014) · The Prostate · doi:10.1002/pros.22776 · Cited by 98
Hypoxia-Inducible Factor-1 Transactivates Transforming Growth Factor-β3 in Trophoblast
Nishi, H., Nakada, T., Hokamura, M., Osakabe, Y., 糸数, 修., Huang, E. L., & Isaka, K. (2004) · Endocrinology · doi:10.1210/en.2003-1639 · Cited by 97
Calvani, M., Comito, G., Giannoni, E., & Chiarugi, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038388 · Cited by 94
Tewari, R., Choudhury, S. R., Ghosh, S., Mehta, V. S., & Sen, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0807-6 · Cited by 93
西, 憲. (2008) · Medical Entomology and Zoology · Cited by 93
Dominant-Negative HIF-3α4 Suppresses VHL-Null Renal Cell Carcinoma Progression
Maynard, M. A., Evans, A. J., Shi, W., Kim, W. Y., Liu, F., & Ohh, M. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4947 · Cited by 92
Cheng, Z., Sun, B., Wang, S., Gao, Y., Zhang, Y., Zhou, H., Jia, G., Wang, Y., Kong, R., Pan, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023752 · Cited by 91
HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammation
Zampell, J. C., Yan, A., Avraham, T., Daluvoy, S. V., Weitman, E. S., & Mehrara, B. J. (2011) · The FASEB Journal · doi:10.1096/fj.11-195321 · Cited by 88
NFκB and HIF display synergistic behaviour during hypoxic inflammation
Brüning, U., Fitzpatrick, S. F., Frank, T. D., Birtwistle, M. R., Taylor, C. T., & Cheong, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0876-2 · Cited by 87
Effects of Histone Deacetylase Inhibitors on HIF-1
Liang, D., Kong, X., & Sang, N. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3409 · Cited by 85
Tamatani, T., Azuma, M., Ashida, Y., Motegi, K., Takashima, R., Harada, K., Kawaguchi, S., & Sato, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.11640 · Cited by 79
Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells
Bhaskara, V. K., Mohanam, I., Rao, J. S., & Mohanam, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030905 · Cited by 78
Shimojo, Y., Akimoto, M., Hisanaga, T., Tanaka, T., Tajima, Y., Honma, Y., & Takenaga, K. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9519-8 · Cited by 73
Shay, J. E. S., Imtiyaz, H. Z., Sivanand, S., Durham, A. C., Skuli, N., Hsu, S., Mucaj, V., Eisinger‐Mathason, T. S. K., Krock, B. L., Giannoukos, D. N., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu004 · Cited by 73
Gariboldi, M. B., Ravizza, R., & Monti, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.011 · Cited by 71
Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation
Kim, H., Park, J., Cho, Y.-S., Cho, C., Kim, J., Shin, H., Chung, D. H., Kim, S. J., & Chun, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.002 · Cited by 69
HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis
Higashiyama, M., Hokari, R., Hozumi, H., Kurihara, C., Ueda, T., Watanabe, C., Tomita, K., Nakamura, M., Komoto, S., Okada, Y., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1011518 · Cited by 68
Yan, H. Q., Huang, X. B., Ke, S. Z., Jiang, Y., Zhang, Y. H., Wang, Y. N., Li, J., & GAO, F. G. (2014) · Cancer Science · doi:10.1111/cas.12478 · Cited by 67
Seebacher, N. A., Richardson, D. R., & Jansson, P. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13079 · Cited by 66
Zhang, J.-L., Cheng, Q., Zhou, Y., Wang, Y., & Chen, X.-M. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.08.003 · Cited by 64
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Miyazaki, S., Kikuchi, H., Iino, I., Uehara, T., Setoguchi, T., Fujita, T., Hiramatsu, Y., Ohta, M., Kamiya, K., Kitagawa, K., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28686 · Cited by 58
Zhu, G., Huang, C., Feng, Z.-Z., Lv, X.-H., & Qiu, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2841-4 · Cited by 57
Wang, R., Cheng, L., Xia, J., Wang, Z., Wu, Q., & Wang, Z. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140226114015 · Cited by 56
Yin, Z., Zhang, Y., Li, Y., Lv, T., Liu, J., & Wang, X. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.04.002 · Cited by 52
Lin, G., Gai, R., Chen, Z., Wang, Y., Liao, S., Dong, R., Zhu, H., Gu, Y., He, Q., & Yang, B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.011 · Cited by 48
Mancini, M., Gariboldi, M. B., Taìana, E., Bonzi, M. C., Craparotta, I., Pagin, M., & Monti, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.269 · Cited by 44
Kato, S., Hayakawa, Y., Sakurai, H., Saiki, I., & Yokoyama, S. (2013) · Cancer Science · doi:10.1111/cas.12336 · Cited by 41
Solito, S., Pinton, L., Damuzzo, V., & Mandruzzato, S. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.678023 · Cited by 40
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α
Zhang, C., Yang, X., Zhang, Q., Guo, Q., He, J., Qin, Q., Zhu, H., Liu, J., Zhan, L., Lü, J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2207-3 · Cited by 35
Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells
Miao, Z., Zhao, T., Wang, Z.-N., Xu, Y., Mao, X., Wu, J.-H., Liu, X., Xu, H., You, Y., & Xu, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-1928-7 · Cited by 30
Chen, W., Hung, W., Kang, W.-Y., Huang, Y., SU, Y., Yang, C.-H., & Chai, C. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00004.x · Cited by 26
Luo, Y., CUI, X., Zhao, J., HAN, Y., Li, M., Lin, Y., Jiang, Y., & Lan, L. (2013) · Oncology Reports · doi:10.3892/or.2013.2905 · Cited by 25
Lavecchia, A., Giovanni, C. D., & Cerchia, C. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.877443 · Cited by 23
Cited by
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., You, L., Nepovimova, E., Heger, Z., Wu, W., Kuca, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 485
Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
Prevarskaya, N., Skryma, R., & Shuba, Y. (2018) · Physiological Reviews · doi:10.1152/physrev.00044.2016 · Cited by 484
NF‐κB and HIF crosstalk in immune responses
D'Ignazio, L., Bandarra, D., & Rocha, S. (2016) · The FEBS Journal · doi:10.1111/febs.13578 · Cited by 363
Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
Van Dyken, P., & Lacoste, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00930 · Cited by 359
Up-down regulation of HIF-1α in cancer progression
Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 283
Metadata
- Authors
- Balamurugan, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2015-04-07
- Volume
- 138
- Issue
- 5
- Pages
- 1058-1066
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1557991089
- Cited by
- 572
- References
- 155
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.